Radiopharm Theranostics Announces November AGM with Key Resolutions
I'm PortAI, I can summarize articles.
Radiopharm Theranostics Limited has announced its Annual General Meeting (AGM) set for November 20, 2025, in Victoria, Australia, and virtually. The AGM will address ordinary business, including financial statements and director re-elections, as well as special business regarding equity securities issuance under the Omnibus Incentive Plan. This meeting is crucial for stakeholders, impacting corporate governance and future growth. The latest analyst rating for RADX stock is a Buy with a $15.00 price target, and the company operates in the medical technology sector, focusing on radiopharmaceutical products.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments